Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1703
| Despition | PITPNA Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg | inquiry |
| ACPP-1499 | Mouse RAPSN Protein (AC1499) | 5 µg | inquiry |
| ACPP-1771 | Human ATG3 Protein (AC1771) | 5 µg | inquiry |
| ACPP-1082 | Human CACYBP Protein (AC1082) | 5 µg | inquiry |
| ACPP-1503 | Human RTP4 Protein (AC1503) | 5 µg | inquiry |
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1352 | Myocilin Blocking Peptide (AC1352) | 250 µg | inquiry |
| ACPP-1737 | Human NCALD Protein (AC1737) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.